Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug

Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has closed the previously announced (May 8, 2019) acquisition of an 80% equity interest in Pharmadrug Production GmbH (“Pharmadrug”) for total consideration of €5.0 million. Pharmadrug is a cash flow positive German pharmaceutical distribution company with over 20 years of operating history and a Schedule I European Union narcotics license allowing for the distribution of medical cannabis to pharmacies in Germany and throughout the Eurozone as markets become legalized. Pharmadrug has supply agreements in place with Bedrocan International B.V., Canadian Licensed Producers, and is currently supplying medical cannabis to pharmacies in Germany.

Keep reading... Show less

Matica Reports First Harvest Completed

Matica Enterprises Inc. (CSE:MMJ) (OTCQB:MMJFF) (39N – Frankfurt) (“Matica” or the “Company”) is pleased to announce the completion of the first cannabis harvest at the Dorval facility of RoyalMax Biotechnology Canada Inc. (“RoyalMax”). This is an important milestone for RoyalMax and Matica as the companies move towards retail and medical sales licensing.

“Our team, working in a state of the art facility, is producing the type of high quality product the market is demanding. This first harvest is important not just for our company but, for Quebec cannabis as a whole. With so few licence holders in the Province, more production of high quality cannabis from Quebec is an absolute must” states Boris Ziger, CEO of Matica, and adds that “I wish to thank our highly committed team and can’t express how proud I am of them.”

Keep reading... Show less

Asterion Invited to Participate in the Cowen Toronto Cannabis Summit

Asterion Cannabis Inc. (P.ASTR) (“Asterion” or the “Company”), announces that it will be attending the Cowen Toronto Cannabis Summit on May 22, 2019 held at The Westin Harbour Castle, Toronto, Canada. Mr. Stephen Van Deventer, Asterion’s Chairman and CEO, has been invited to sit as one of three panelists on the Emerging Cannabis Companies Panel, to discuss Asterion’s domestic and international opportunities.

Mr. Stephen Van Deventer commented, “I am pleased to be representing Asterion as part of the Emerging Cannabis Companies panel, along with representatives of Pyxus International, Inc. and Sundial Growers Inc. Asterion looks forward to participating in interesting discussions about opportunities and trends in this evolving cannabis market space.”

Keep reading... Show less

TransCanna Executes LOI to Acquire Award-Winning Cannabis Brand SolDaze

Transcanna Holdings Inc. (CSE:TCAN) (FSE:TH8) (“TransCanna” or the “Company”) is pleased to announce today the execution of a non-binding Letter of Intent dated May 15, 2019 (“LOI”) with Tres Ojos Naturals, LLC d/b/a SolDaze (“SolDaze”), a limited liability company from Santa Cruz, California, to acquire the branding asset package, Soldaze (the “Assets”). SolDaze produces cannabis-infused fruit snacks in California. For more information on SolDaze product lines, please see their website: www.soldazesnacks.com.

“Having reviewed over 100 branded products in California, we’ve been extremely selective in our acquisition vetting process. Our three mandatory acquisition criteria include SKU velocity, upward trending revenues, and products that differentiate themselves in the marketplace. The snack line from SolDaze, and specifically the cannabis-infused mango products, meets all three requirements,” stated Jim Pakulis, CEO of TransCanna.

Keep reading... Show less

1933 Industries to Present at the 3rd Annual Canaccord Genuity Cannabis Conference and at the Cannastocks 2019 Q1 Investor Conference in New York this Week

1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF) (OTCQX:TGIFF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD wellness products, is pleased to report that Mr. Chris Rebentisch, USA COO and Founder of the Company’s Infused MFG. subsidiary, will present to an investor audience this week in New York during two highly anticipated events in the cannabis industry.

3rd Annual Canaccord Genuity Cannabis Conference

Keep reading... Show less

Khiron Provides Update on Transaction to Acquire NettaGrowth

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America, reports that the Company’s previously announced agreement for the acquisition (the “Acquisition”) of NettaGrowth International Inc. (“NettaGrowth”), which at closing will own all of the outstanding shares of a Uruguayan company, Dormul S.A. (“Dormul”), is progressing as planned and the Company is in the latter stages of securing local regulatory approvals in Uruguay for the completion of the Acquisition. The Company has received conditional approval for the Acquisition from the TSX Venture Exchange Inc. (“TSXV”).

At this time, there has been no change to the status of the license applications of Dormul. The parties anticipate completing the Acquisition by the end of June 2019, subject to the satisfaction or waiver of all closing conditions and receipt of all regulatory approvals.

Keep reading... Show less